Mattias Paulsson
Current CEO. A licensed pharmacist and Associate Professor in Clinical Pharmacy. Since 2015, he has been a pioneer in implementing 3D-printed medicines for extemporaneous manufacturing in human medicine. Founded 2 companies.
About Us
The team behind Extem Pharma
Christel Bergström
Professor of Molecular Pharmaceutics at Uppsala University, and an internationally recognized leader in pharmaceutical formulation. With over 25 years of experience, Christel brings unparalleled expertise and a global network spanning academia and industry. Founded 4 companies.
Henrik Rönnberg
Professor of Veterinary Pharmacology, DiplECVIM-CA (Oncology) at the Swedish University of Agricultural Sciences. Henrik is a world renowned expert in comparative clinical oncology with over 25 years of research experience and significant contributions to veterinary and human clinical trials. Founded 3 companies.
Extem Pharma AB
News and Updates
Welcome to our news section! Here you will find the latest updates from Extem Pharma.
Mattias Paulsson, Aug 2025
Explaining 3D-Printed Drugs: Extem Pharma founders on Swedish Television
At our company, two of our founders were recently featured on Swedish public television (SVT), showcasing 3D‑printing for on‑demand, customized pharmaceuticals. From lab‑made “vanilla” to “tuna‑flavored” medicines, this technology makes it possible to design doses and flavours that match the individual patient needs.
Vanilj eller tonfisk – här i labbet skapas 3D-printade läkemedel | SVT Nyheter
Mattias Paulsson, July 2025
Extem Pharma has now secured its production facility
Extem Pharma has signed a lease agreement for its first manufacturing site, located at Vallongatan 1 in Uppsala. The facility will be equipped for GMP-compliant small-scale pharmaceutical production and 3D printing of personalised medicines.
Mattias Paulsson, July 2025
Safer Medicines for Children – Powered by 3D Printing
Up to 37% of oral drugs given to children are manipulated before use — split, crushed, or dispersed — leading to dosing errors and safety risks.
One of our co-founders is the lead author of a recent scientific review highlighting these challenges and the need for personalised manufacturing in paediatrics.
Extem Pharma offers a better way: age-appropriate, 3D-printed medicines tailored to each patient.
Mattias Paulsson, June 2025
Ongoing Seed Round for Strategic Investors
Extem Pharma is currently raising capital through a directed share issue to accelerate the build-up of its production site and scale its personalised medicine platform.
Questions? Please contact us on information@extempharma.com
Mattias Paulsson, May 2025
Extem Pharma, Uppsala and Craft Health, Singapore embark on strategic partnership
We’re so happy to announce our collaboration with Craft Health, a pioneering company based in Singapore specializing in 3D printing of pharmaceuticals.
This partnership strengthens Extem Pharma’s commitment to personalized medicine and supports our mission to bring innovative, patient-friendly drug formulations to the market.
Together, we aim to accelerate the development and adoption of 3D-printed dosage forms in clinical practice. Please read more about Craft Health here.
Questions? Please contact us on information@extempharma.com
Mattias Paulsson, March 2025
The company turns one and is awarded the Bona Postulata price! 🥳
One year ago, we officially launched Extem Pharma - and what a year it's been! We are also proud to announce that we have been awarded the Business Prize Bona Postulata! Thank you to everyone who has supported on this journey!
Mattias Paulsson, Feb 2025
Extem Pharma is now on LinkedIn
We're excited to announce that Extem Pharma has joined LinkedIn. Follow us to stay updated on our latest developments.